Advantage Energy (TSE:AAV – Free Report) (NYSE:AAV) had its target price reduced by Desjardins from C$13.25 to C$13.00 in a research report released on Tuesday morning, Marketbeat reports. Desjardins currently has a buy rating on the stock. A number of other brokerages have also recently issued reports on AAV. TD Securities restated a buy rating […]
The hearing has returned for the first person who has received gene therapy for treating genetic hearing loss in the U.S. Initial results from Akouos Inc.’s phase I/II study showed that within 30 days of receiving AK-OTOF-101, pharmacologic hearing was restored to an 11-year-old who had profound hearing loss from birth.
Advantage Energy Ltd. (TSE:AAV – Free Report) (NYSE:AAV) – Equities researchers at Atb Cap Markets issued their FY2026 earnings estimates for shares of Advantage Energy in a research report issued on Wednesday, January 17th. Atb Cap Markets analyst A. Arif forecasts that the company will earn $0.85 per share for the year. Atb Cap Markets […]